Canada - English - Health Canada

hikma canada limited - bendamustine hydrochloride - powder for solution - 25mg - bendamustine hydrochloride 25mg

Canada - English - Health Canada

hikma canada limited - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - bendamustine hydrochloride, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - bendamustine hydrochloride, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - bendamustine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 100 milligram - bendamustine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

chemi s.p.a. - bendamustine hydrochloride 100 mg - eq. bendamustine 90,8 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 25 mg - bendamustine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

chemi s.p.a. - bendamustine hydrochloride 100 mg - eq. bendamustine 90,8 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 100 mg - bendamustine